Science and Research

ProVENT Study

A prospective, non-interventional, multicenter observational study to evaluate the effectiveness, patterns of use, and patient-reported outcomes of dupilumab under real-world conditions in patients with severe inadequately controlled asthma.

Study details
DZL Disease Area: AA
DZL Disease Area: AA
Study Type: Observational
Study Type: Observational
DZL Role: DZL on steering board
DZL Role: DZL on steering board
Funding: Externally - industry, Externally - public
Funding: Externally - industry, Externally - public
DZL Participating Sites: ARCN
DZL Participating Sites: ARCN
Start Date: 01.01.2020
Completion Date: 31.12.2030
Status: Recruiting
Status: Recruiting
DZL on steering board
Link to Study


chevron-down